# Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye

> **NCT03183089** · PHASE4 · COMPLETED · sponsor: **The Mentholatum Company** · enrollment: 80 (actual)

## Conditions studied

- Dry Eye Syndromes
- Dry Eye

## Interventions

- **DRUG:** Rohto Dry-Aid®
- **DRUG:** Systane® Ultra

## Key facts

- **NCT ID:** NCT03183089
- **Lead sponsor:** The Mentholatum Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-03
- **Primary completion:** 2016-01-04
- **Final completion:** 2016-01-04
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183089, "Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03183089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*